HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy.

AbstractBACKGROUND:
Both basic and clinical research has demonstrated that antiepileptic drugs can be effective in alleviating neuropathic pain. It was hypothesized that oxcarbazepine might be effective in reducing the symptoms of painful diabetic neuropathy.
AIMS:
To investigate the long-term efficacy and safety of oxcarbazepine in symptoms of painful diabetic neuropathy.
MATERIALS AND METHODS:
This study included thirty-eight painful diabetic neuropathy patients, which were screened with clinical assessment and electrophysiological studies. The efficacy and safety of oxcarbazepine were evaluated according to the changes in pain intensity and social interference subitems scores of Short-form Brief Pain Inventory besides electrophysiological studies at the end of six months of the treatment.
STATISTICAL ANALYSIS:
The Students t, Mann-Whitney U and Rank Sum test and Chi-square tests were applied to examine variables differences. The level of statistical significance was chosen to be P<0.05.
RESULTS:
A significant difference was found in all of subitems of pain intensity and social interference at the end of the study according to the baseline scores. Improvement was observed in 52.7%, 63.1%, 55.3% and 63.2% of patients for worst, least, average and pain right now at the end of six months, respectively. Improvement was observed as 60.6%, 63.2%, 52.6%, 60.5%, 68.4% and 63.2% for general activity, mood, walk, work, people relations, sleep and life enjoyment subitems, respectively. None of these patients had any prominent side effect leading to discontinue the treatment.
CONCLUSION:
Long-term oxcarbazepine treatment was found to be effective and safe in the symptoms of painful diabetic neuropathy.
AuthorsA Kemal Erdemoglu, Ayhan Varlibas
JournalNeurology India (Neurol India) Vol. 54 Issue 2 Pg. 173-7; discussion 177 (Jun 2006) ISSN: 0028-3886 [Print] India
PMID16804263 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Carbamazepine
  • Oxcarbazepine
Topics
  • Adolescent
  • Adult
  • Aged
  • Carbamazepine (adverse effects, analogs & derivatives, therapeutic use)
  • Diabetes Mellitus, Type 2
  • Diabetic Neuropathies (drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxcarbazepine
  • Pain (drug therapy, etiology)
  • Pain Measurement

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: